Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 29:13:e19379.
doi: 10.7717/peerj.19379. eCollection 2025.

Clinical significance of platelet-to-white blood cell ratio in patients with Wilson disease: a retrospective cohort study

Affiliations

Clinical significance of platelet-to-white blood cell ratio in patients with Wilson disease: a retrospective cohort study

Hao-Jie Zhong et al. PeerJ. .

Abstract

Objective: To assess the correlation between the platelet-to-white blood cell ratio (PWR) and the severity of liver dysfunction, hepatic complications, and prognosis in Wilson disease (WD) patients.

Methods: A retrospective analysis was conducted on medical records from January 1, 2016, to March 30, 2022. Both univariate and multivariate analyses were performed to examine the impact of a low PWR (<26.3) on WD severity, liver complications, and disease progression. Additionally, the effect of splenectomy on PWR was evaluated.

Results: The study included 315 patients with WD, among whom 105 had a low PWR and 210 had a high PWR. Those with low PWR exhibited significantly elevated levels of bilirubin, international normalized ratio, prothrombin time, procollagen type-III N-terminal propeptide, type IV collagen, hyaluronic acid, and portal vein diameter. Conversely, they had lower levels of albumin, total cholesterol, low-density lipoprotein cholesterol, and triglycerides (all P < 0.05). A low PWR correlated with a greater incidence of splenomegaly/hypersplenism, esophagogastric varices, and ascites (all P < 0.05). Furthermore, low PWR independently predicted hepatic decompensation (P < 0.05), and splenectomy led to a marked increase in PWR among WD patients (P < 0.001).

Conclusion: A low PWR in WD patients is linked to heightened disease severity, increased risk of liver complications, and rapid progression to decompensation. The results imply that splenectomy, by enhancing PWR, may serve as a viable strategy to slow WD progression.

Keywords: Blood platelets; Hepatolenticular degeneration; Leukocytes; Liver cirrhosis; Splenectomy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1. Receiver operating characteristic (ROC) curves of platelets, WBCs, or PWR for hepatic decompensation in patients with WD.
PWR, platelet-to-white blood cell ratio; WBC, white blood cell; WD, Wilson disease.
Figure 2
Figure 2. Impact of splenectomy on PWR in patients with WD.
(A) Comparison of PWR between WD patients with splenomegaly who underwent splenectomy (n = 32) and those who did not (n = 144). (B) Pre-and post-splenectomy PWR analysis in WD patients (n = 9) PWR, platelet-to-white blood cell ratio; WD, Wilson disease.

Similar articles

References

    1. Adamstein NH, Cornel JH, Davidson M, Libby P, de Remigis A, Jensen C, Ekstrom K, Ridker PM. Association of interleukin 6 inhibition with ziltivekimab and the neutrophil-lymphocyte ratio: a secondary analysis of the RESCUE clinical trial. JAMA Cardiology. 2023;8(2):177–181. doi: 10.1001/jamacardio.2022.4277. - DOI - PMC - PubMed
    1. Adamstein NH, MacFadyen JG, Rose LM, Glynn RJ, Dey AK, Libby P, Tabas IA, Mehta NN, Ridker PM. The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. European Heart Journal. 2021;42(9):896–903. doi: 10.1093/eurheartj/ehaa1034. - DOI - PMC - PubMed
    1. Amalia L, Dalimonthe NZ. Clinical significance of platelet-to-white blood cell ratio (PWR) and National Institute of Health Stroke Scale (NIHSS) in acute ischemic stroke. Heliyon. 2020;6(10):e05033. doi: 10.1016/j.heliyon.2020.e05033. - DOI - PMC - PubMed
    1. Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, Klaffke S, Joyce CJ, Dhawan A, Hadzic N, Mieli-Vergani G, Kirk R, Elizabeth Allen K, Nicholl D, Wong S, Griffiths W, Smithson S, Giffin N, Taha A, Connolly S, Gillett GT, Tanner S, Bonham J, Sharrack B, Palotie A, Rattray M, Dalton A, Bandmann O. A genetic study of Wilson’s disease in the United Kingdom. Brain. 2013;136(5):1476–1487. doi: 10.1093/brain/awt035. - DOI - PMC - PubMed
    1. Colapietro F, Maisonneuve P, Lytvyak E, Beuers U, Verdonk RC, van der Meer AJ, van Hoek B, Kuiken SD, Brouwer JT, Muratori P, Aghemo A, Carella F, van den Berg AP, Zachou K, Dalekos GN, Di Zeo-Sanchez DE, Robles M, Andrade RJ, Montano-Loza AJ, van den Brand FF, Slooter CD, Macedo G, Liberal R, de Boer YS, Lleo A, Dutch AIH Study Group. International Autoimmune Hepatitis Group Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis. Journal of Hepatology. 2024;80(1):53–61. doi: 10.1016/j.jhep.2023.09.010. - DOI - PubMed

LinkOut - more resources